99 related articles for article (PubMed ID: 17517063)
1. Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection.
Andréo U; Maillard P; Kalinina O; Walic M; Meurs E; Martinot M; Marcellin P; Budkowska A
Cell Microbiol; 2007 Oct; 9(10):2445-56. PubMed ID: 17517063
[TBL] [Abstract][Full Text] [Related]
2. Infection of Hepatocytes With HCV Increases Cell Surface Levels of Heparan Sulfate Proteoglycans, Uptake of Cholesterol and Lipoprotein, and Virus Entry by Up-regulating SMAD6 and SMAD7.
Zhang F; Sodroski C; Cha H; Li Q; Liang TJ
Gastroenterology; 2017 Jan; 152(1):257-270.e7. PubMed ID: 27693511
[TBL] [Abstract][Full Text] [Related]
3. Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps.
Dao Thi VL; Granier C; Zeisel MB; Guérin M; Mancip J; Granio O; Penin F; Lavillette D; Bartenschlager R; Baumert TF; Cosset FL; Dreux M
J Biol Chem; 2012 Sep; 287(37):31242-57. PubMed ID: 22767607
[TBL] [Abstract][Full Text] [Related]
4. Primary hepatocytes as targets for hepatitis C virus replication.
Farquhar MJ; McKeating JA
J Viral Hepat; 2008 Dec; 15(12):849-54. PubMed ID: 19087224
[TBL] [Abstract][Full Text] [Related]
5. Building a mechanistic mathematical model of hepatitis C virus entry.
Kalemera M; Mincheva D; Grove J; Illingworth CJR
PLoS Comput Biol; 2019 Mar; 15(3):e1006905. PubMed ID: 30883541
[TBL] [Abstract][Full Text] [Related]
6. Interplay among cellular polarization, lipoprotein metabolism and hepatitis C virus entry.
Benedicto I; Molina-Jiménez F; Moreno-Otero R; López-Cabrera M; Majano PL
World J Gastroenterol; 2011 Jun; 17(22):2683-90. PubMed ID: 21734774
[TBL] [Abstract][Full Text] [Related]
7. The rate of hepatitis C virus infection initiation in vitro is directly related to particle density.
Sabahi A; Marsh KA; Dahari H; Corcoran P; Lamora JM; Yu X; Garry RF; Uprichard SL
Virology; 2010 Nov; 407(1):110-9. PubMed ID: 20800257
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in hepatitis C virus cell entry.
Bartosch B; Dubuisson J
Viruses; 2010 Mar; 2(3):692-709. PubMed ID: 21994653
[TBL] [Abstract][Full Text] [Related]
9. Myosin 9 and N-glycans jointly regulate human papillomavirus entry.
Zhang Y; Liu W; He F; Liu YJ; Jiang H; Hao C; Wang W
J Biol Chem; 2024 Feb; 300(2):105660. PubMed ID: 38242322
[TBL] [Abstract][Full Text] [Related]
10. Targeting host-specific metabolic pathways-opportunities and challenges for anti-infective therapy.
Konaklieva MI; Plotkin BJ
Front Mol Biosci; 2024; 11():1338567. PubMed ID: 38455763
[TBL] [Abstract][Full Text] [Related]
11. Cellular factors involved in the hepatitis C virus life cycle.
Li HC; Yang CH; Lo SY
World J Gastroenterol; 2021 Jul; 27(28):4555-4581. PubMed ID: 34366623
[TBL] [Abstract][Full Text] [Related]
12. Changes of Gut-Microbiota-Liver Axis in Hepatitis C Virus Infection.
El-Mowafy M; Elgaml A; El-Mesery M; Sultan S; Ahmed TAE; Gomaa AI; Aly M; Mottawea W
Biology (Basel); 2021 Jan; 10(1):. PubMed ID: 33451143
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of Ephrin receptor and PPAR signaling pathways in neural progenitor cells infected by Zika virus.
Thulasi Raman SN; Latreille E; Gao J; Zhang W; Wu J; Russell MS; Walrond L; Cyr T; Lavoie JR; Safronetz D; Cao J; Sauve S; Farnsworth A; Chen W; Shi PY; Wang Y; Wang L; Rosu-Myles M; Li X
Emerg Microbes Infect; 2020 Dec; 9(1):2046-2060. PubMed ID: 32873194
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus entry into the hepatocyte.
Belouzard S; Cocquerel L; Dubuisson J
Cent Eur J Biol; 2011; 6(6):933-945. PubMed ID: 32215118
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C Virus Entry: An Intriguingly Complex and Highly Regulated Process.
Colpitts CC; Tsai PL; Zeisel MB
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32197477
[TBL] [Abstract][Full Text] [Related]
16. Functional Study of the C-Terminal Part of the Hepatitis C Virus E1 Ectodomain.
Moustafa RI; Haddad JG; Linna L; Hanoulle X; Descamps V; Mesalam AA; Baumert TF; Duverlie G; Meuleman P; Dubuisson J; Lavie M
J Virol; 2018 Oct; 92(20):. PubMed ID: 30068644
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.
Crouchet E; Baumert TF; Schuster C
Expert Rev Proteomics; 2017 Jul; 14(7):593-606. PubMed ID: 28625086
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein(a) inhibits hepatitis C virus entry through interaction with infectious particles.
Oliveira C; Fournier C; Descamps V; Morel V; Scipione CA; Romagnuolo R; Koschinsky ML; Boullier A; Marcelo P; Domon JM; Brochot E; Duverlie G; Francois C; Castelain S; Helle F
Hepatology; 2017 Jun; 65(6):1851-1864. PubMed ID: 28152568
[TBL] [Abstract][Full Text] [Related]
19. Relationship Between the Physicochemical Properties of Lipid Nanoparticles and the Quality of siRNA Delivery to Liver Cells.
Sato Y; Hatakeyama H; Hyodo M; Harashima H
Mol Ther; 2016 Apr; 24(4):788-95. PubMed ID: 26678452
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
